NCT06941090

Brief Summary

The gut microbiota is currently attracting increasing attention from the scientific community and also from the general public, as evidence of its role in human physiology has been highlighted. Microbial signatures have also been associated with various pathologies (e.g. obesity, diabetes, gastrointestinal disorders, neurodegenerative diseases), but the causality of these associations is still uncertain. Among the factors that may influence the composition of the gut microbiota (e.g. lifestyle, hygiene, medication, genetics, environment), nutrition would a major role. The major changes in lifestyle and diet observed over recent decades are strongly suspected of disrpting the host-gut microbiota balance. In addition to their nutrient content, our diets also contain other bioactive compounds (e.g. polyphenols) and raise new issues (e.g. temporal structure of diets, food processing, presence of additives or contaminants such as pesticide residues, intake of dietary supplements, dietary exclusions, glycemic index) that is necessary to take into account. Thus, it is mandatory to explore and characterize in a more precise way, within large samples consisting of individuals with varied characteristics, the way in which the composition of the gut microbiota is influenced by the host's diet and its health consequences. The aim of this research is therefore to study the links between nutrition, gut microbiota profiles and health. To do this, the research will implement large-scale stool sample collection from participants in the NutriNet-Santé cohort ("Nutrinautes"), thus constituting a "microbiota" sub-cohort. A target of N=10,000 participants in the NutriNet-Santé cohort will be recruited on a voluntary basis. A selection will then be made among Nutrinautes willing to participate in the research (which may be more numerous than necessary) to maximize the diversity of profiles. Participants will be informed of their selection or non-selection by e-mail. A second stool sample will also be collected 2-3 months after the first for a sub-sample of N=300 to assess intra-individual variability in microbiota profiles. The selected participants will receive a stool self-sampling kit with detailed instructions by post to their home address. The pseudonymized samples will be returned by mail by the participant to the processing laboratory, which will determine their gut microbiota characteristics by 16S rDNA sequencing and/or " shotgun " sequencing. The gut microbiota profiles will then be analyzed in a pseudonymised manner in association with diet and health, using data collected as part of the NutriNet-Santé cohort follow-up (e.g. food consumption, prevalence and incidence of pathologies, biological data, anthropometric characteristics, medication intake, socio-demographic characteristics, lifestyle).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for not_applicable

Timeline
92mo left

Started Dec 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress25%
Dec 2023Dec 2033

Study Start

First participant enrolled

December 15, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 16, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 23, 2025

Completed
8.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2033

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2033

Last Updated

April 23, 2025

Status Verified

April 1, 2025

Enrollment Period

10 years

First QC Date

April 16, 2025

Last Update Submit

April 16, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Characterization of gut microbiota profile by 16S r RNA gene sequencing

    Performed on self sampling of stools at home. It is used to characterize the taxonomic profiles of intestinal microbiota. It will be applied on all samples

    At inclusion, 2 to 3 months later

  • Characterization of gut microbiota profile by " shotgun " metagenomic sequencing

    Performed on self sampling of stools at home. It provides more detailled characterization of the taxonomic and functional profiles of the intestinal microbiota. It will be applied to a smaller number of samples (no more than 300).

    At inclusion, 2 to 3 months later

Study Arms (1)

stool sampling

EXPERIMENTAL

The research consists in collecting stool samples from a sub-sample of participants already included in the NutriNet-Santé cohort. The stool collection will enable us to study the characteristics of the intestinal microbiota in relation to nutrition on the one hand, and health on the other, based on data collected during participation in the NutriNet-Santé cohort.

Other: sampling stool

Interventions

Participants will receive a self-sampling stool kit with detailed instructions by mail to their home address. Samples will be mailed back by the participant to the treatment laboratory, which will determine the characteristics of their intestinal microbiota.

stool sampling

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant in the NutriNet-Santé cohort
  • Age ≥ 18 years
  • Resident of metropolitan France
  • Written comprehension frenc

You may not qualify if:

  • Person subject to a safeguard of justice measure
  • Person belonging to one of the categories of vulnerable persons
  • Diagnosis of COVID-19 (clinically or by PCR) in the month prior to collection
  • Contact with a COVID-19 patient in the month prior to collection
  • Suspicion of COVID-19 in the month preceding collection (clinical signs of infection : fever associated with headache, respiratory signs, os anosmia/ageusia)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

EREN SMBH Université Sorbonne Paris Nord

Bobigny, France

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2025

First Posted

April 23, 2025

Study Start

December 15, 2023

Primary Completion (Estimated)

December 15, 2033

Study Completion (Estimated)

December 15, 2033

Last Updated

April 23, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations